Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1114 | 1045 | 1249 | 1092 | 1468 | 1685 |
Fund Return | 11.39% | 4.5% | 24.87% | 2.98% | 7.98% | 5.35% |
Place in category | 61 | 70 | 64 | 54 | 60 | 30 |
% in Category | 72 | 83 | 66 | 67 | 74 | 66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 35.15B | 12.98 | 7.81 | 11.10 | ||
T. Rowe Price Blue Chip Growth | 31.67B | 28.18 | 6.97 | 14.72 | ||
T. Rowe Price Capital AppreciationI | 28.68B | 13.07 | 7.94 | - | ||
T. Rowe Price Blue Chip Growth I | 28.53B | 28.30 | 7.11 | - | ||
T. Rowe Price Instl Large Cap Growt | 21.95B | 24.63 | 7.82 | 16.08 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard European Stock Index Adm | 5.18B | 12.78 | 6.19 | 5.82 | ||
Fidelity Europe | 553.11M | 13.10 | 1.14 | 5.11 | ||
Vanguard European Stock Index I | 904.87M | 12.79 | 6.22 | 5.85 | ||
DFA Continental Small Company I | 795.44M | 10.43 | 2.39 | 8.05 | ||
Brown Advisory WMC Strat Eurp Eq In | 334.39M | 18.86 | 9.22 | 8.62 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.89 | 745.4 | -0.96% | |
ASML Holding | NL0010273215 | 4.30 | 624.00 | +0.94% | |
SAP | DE0007164600 | 3.87 | 215.830 | +0.95% | |
AstraZeneca | GB0009895292 | 3.41 | 10,114.0 | -8.40% | |
Unilever | GB00B10RZP78 | 2.83 | 56.30 | -0.07% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review